Thank you for visiting a member of the Biotechnology Innovation Organization (BIO) family of websites.  BIO and possibly affiliated organizations (“BIO” “we,” “our,” “us”) maintain these sites (each, strictly for reference in this privacy policy, a “BIO Site” and collectively “BIO Sites”). This privacy policy (the "Privacy Policy") applies to BIO Sites, mobile applications, and other online services that link to this Privacy Policy (the “Services”). By using the Services, you agree to the terms of this Privacy Policy.  In addition, by using the Services, you agree to the terms of the BIO TERMS OF USE, which govern your use of the Services.   Please note that the Privacy Policy does not apply to other websites of other companies, organizations or our members to which we may link, third party sites that link to us, or to our off-line activities.IF YOU DO NOT AGREE WITH ANY TERMS OR PRACTICES DESCRIBED IN THIS PRIVACY POLICY, OR BIO’S TERMS OF USE, THEN PLEASE DO NOT USE THE SERVICES.Information CollectionGenerally, you are not required to provide information about yourself when you visit the Services.  You can browse most of our BIO Sites and view our content anonymously (except regarding some information like Google analytics or “informatics”).  The type and amount of information BIO collects about you varies according to how you use the Services, BIO Sites or other BIO operations and events.  However, we may ask you for (or collect from you) some or all of the following types of information when you access various content or features, submit information to us, or directly contact us with questions or feedback:Contact information, such as name, e-mail address, phone number and postal address;Demographic information, such as gender, age, income, and residency status;Geolocation information and zip code information;Communication preferences and information about your interests;Search queries;Correspondence and other information that…

Thank you for being a member of BIO. Join the conversation and let everyone know you're a member using the resources below! 

To be eligible for membership in BIO, a firm or organization must fit into one of the membership categories outlined in BIO’s bylaws (i.e., Core, Associate, Affiliate, and Center members). Further, membership in BIO is open only to firms or organizations that generally support BIO’s public policy positions, and whose own positions and business practices are generally consistent with BIO’s reputation and its policies and principles in support of innovation, including intellectual property rights. As part of the application and membership renewal process, each firm or organization is required to affirm that it meets such criteria.As an indicium of a Core Member’s “support for innovation,” an important criterion includes an assessment of whether a Core Member company invests significantly in innovative (i.e., new and novel) biotechnological research and development (R&D) activities.Beyond these core requirements of membership, BIO expects that its members will not engage in conduct that is detrimental to the purpose or reputation of the organization.BIO Statements and Principles regarding Biotech Social Responsibilities:In addition to BIO’s membership criteria, BIO’s Board of Directors has, over the years, adopted a series of official Statements and Principles that help to set expectations regarding the social responsibilities of our members and the broader biotechnology community, and to encourage societally beneficial conduct. While non-exhaustive, we have provided below the links to some of the most important Statements and Principles adopted by BIO’s Board.Developing an Inclusive and Impactful Approach to Transparency for Biotechnology in Food & AgricultureStatement of BIO Ethical PrinciplesPrinciples on Protecting Research and Research ParticipantsPrinciples on Responsible Sharing of Truthful and Non-Misleading Information About Medicines With Health Care Professionals and PayersStatement of Ethical Principles for the Care and Use of Animals in…

BIO has long expressed its commitment to the use of biotechnology only to benefit humankind. BIO's Statement of Ethical Principles contains several provisions that describe responsible uses of biotechnology and ethical behavior standards developed by the biotechnology industry. After the September 11, 2001 attack on America, questions have been raised about broader uses of biotechnology, including its use to detect, diagnose, prevent, or treat victims of possible future biological attacks as well as the potential for misuse of the technology.BIO hereby re-affirms its long-standing policy opposing the use of biotechnology to develop weapons. As importantly, however, BIO strongly supports the use of biotechnology to promote and protect the public health and national security. To these ends, appropriate uses of biotechnology include the research, development, and commercialization of products and services to detect, diagnose, protect, and treat all people against harmful pathogens and other agents.Such products should be developed and distributed under statutory, regulatory and ethical frameworks that address issues including informed consent for patients and participants in clinical trials, independent review of clinical trial protocols, licensing and other importation and exportation rules, and technology transfer. BIO member companies believe in the responsible progress - and use - of science. Biotechnology companies support the use of appropriate safeguards for technologies, including security for employees and facilities.BIO will continue to work with government agencies, policy makers, and other leaders to develop policies and procedures that embody these important bioethical principles.To improve public understanding about biotechnology and how it can maintain and improve public health and security, BIO and its member companies also will educate policy makers and the public.Through biotechnology more than 100 new, breakthrough biopharmaceuticals, vaccines, and…

BIO and its members share a commitment to discovering and developing innovative medicines to fight and cure disease and improve the lives of patients.  In an effort to achieve our shared goals of bringing new treatments to patients, BIO and its members often work together with patient advocacy organizations to better understand the patients we serve, to help raise awareness and understanding of a disease, and to advance patient-focused public policies.  BIO and its members are proud of the many collaborations they have with the patient advocacy community.  To ensure that these collaborations respect the independence of all partners and are built on integrity and trust, BIO developed a set of guiding principles which reflect these values to help inform interactions between BIO members and the patient advocacy community. 

IntroductionIn the era of data-driven medicine, where all parties seek more, not less, information about the safety, effectiveness, and value of treatments, fostering informed communications among all stakeholders is critical. Today, the wealth of information about medicines is more comprehensive and complex than ever before. Scientific knowledge and new findings go far beyond data sets produced from clinical trials, often are outside the scope of the parameters established by Food and Drug Administration (FDA) regulations, and often outdate the FDAapproved labeling. In addition to information in the approved labeling for medicines, biopharmaceutical companies continually generate and collect important data and analyses that can benefit patient care and enhance the efficiency of our health care system.To exercise sound medical judgment in treating patients, health care professionals must understand the full range of treatment options, including both established and emerging information about available medications. Biopharmaceutical companies are uniquely positioned to help health care professionals achieve the best outcomes for patients, because companies can provide timely, accurate, and comprehensive information about both approved and unapproved uses of the medications they research, develop, and bring to patients. PhRMA, BIO and their members believe that the availability of a wider range of truthful and non-misleading information can help health care professionals and payers make better informed medical decisions for their patients, which in turn will benefit patients.In order to support the best use of scientific information for patient care, PhRMA and BIO endorse these Principles on Responsible Sharing of Truthful and Non-Misleading Information About Medicines with Health Care Professionals and Payers. These Principles are intended to form the basis for defining new and clear regulatory standards governing responsible, truthful and non-misleading…

The Biotechnology Innovation Organization (BIO) is committed to the socially responsible development and use of biotechnology to help save or improve lives, improve the abundance of food and reduce agriculture’s environmental impact, develop renewable sources of energy, and reduce the production of pollution in manufacturing.  We encourage discussion of the ethical and social implications of scientific developments in biotechnology.  As our companies work to develop promising new technologies to benefit humankind, applications of these technologies also may raise ethical questions.  To help us examine bioethics issues as they arise, we have an established BIO Board Standing Committee on Bioethics.Our Bioethics Committee was established to define, articulate, and communicate effectively BIO's positions with respect to major bioethics issues.  As part of this commitment, we have developed these principles and post them publicly.PreambleBIO represents biotechnology companies, academic institutions, state biotechnology centers, and related organizations throughout the United States and in more than 30 other countries.  The members of BIO apply biological knowledge and techniques to develop products and services for use in health care, agriculture, energy, environmental remediation, and other fields.  The benefits of these products and services include saving lives threatened by disease, protecting the blood supply from some infectious agents, increasing food production on less land and with fewer chemical, water, and energy inputs, diversifying energy sources, and aiding the clean-up of hazardous wastes.While biotechnology can greatly improve the quality of life, we recognize that this technology should be approached with an appropriate mixture of enthusiasm, oversight and humility.  Biotechnology can provide useful tools for combating disease, hunger, climate change, and environmental contamination, but it should not be viewed as a…